These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8969402)

  • 1. Hematologic changes in a patient with heparin-induced thrombocytopenia who underwent cardiopulmonary bypass after ancrod defibrinogenation.
    Spiess BD; Gernsheimer T; Vocelka C; Chandler WL; Benak A; Joy JV; Wright I; Hofer BO
    J Cardiothorac Vasc Anesth; 1996 Dec; 10(7):918-21. PubMed ID: 8969402
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia.
    Kanagasabay RR; Unsworth-White MJ; Robinson G; Bevan D; Farnsworth G; Haxby EJ; Smith EE
    Ann Thorac Surg; 1998 Aug; 66(2):567-9. PubMed ID: 9725413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis.
    Teasdale SJ; Zulys VJ; Mycyk T; Baird RJ; Glynn MF
    Ann Thorac Surg; 1989 Nov; 48(5):712-3. PubMed ID: 2818066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal activated clotting time despite adequate anticoagulation with ancrod in a patient with heparin-associated thrombocytopenia and thrombosis undergoing cardiopulmonary bypass.
    Spiekermann BF; Lake CL; Rich GF; Humphries JE
    Anesthesiology; 1994 Mar; 80(3):686-8. PubMed ID: 8141466
    [No Abstract]   [Full Text] [Related]  

  • 5. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Methods Mol Med; 2004; 93():61-82. PubMed ID: 14733328
    [No Abstract]   [Full Text] [Related]  

  • 6. Ancrod: the use of snake venom in the treatment of patients with heparin-induced thrombocytopenia and thrombosis undergoing coronary artery bypass grafting: nursing management.
    Lathan LO; Staggers SL
    Heart Lung; 1996; 25(6):451-60; quiz 461-2. PubMed ID: 8950124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia and thrombosis syndrome after cardiopulmonary bypass.
    Holmes-Ghosh E
    Am J Crit Care; 2000 Jul; 9(4):276-8. PubMed ID: 10888150
    [No Abstract]   [Full Text] [Related]  

  • 8. Ancrod infusion for anticoagulation during and after PTCA in a patient with heparin-induced thrombocytopenia.
    Moore JA; Burket MW; Puri S; Temesy-Armos P; Lachant N; Skeel R
    Cathet Cardiovasc Diagn; 1994 Jul; 32(3):286-7. PubMed ID: 7954782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparinless cardiopulmonary bypass with ancrod.
    O-Yurvati AH; Laub GW; Southgate TJ; McGrath LB
    Ann Thorac Surg; 1994 Jun; 57(6):1656-8. PubMed ID: 8010823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant hirudin.
    Koster A; Kuppe H; Hetzer R; Sodian R; Crystal GJ; Mertzlufft F
    Anesthesiology; 1998 Sep; 89(3):777-80. PubMed ID: 9743416
    [No Abstract]   [Full Text] [Related]  

  • 11. Budd--Chiari syndrome and heparin-induced thrombocytopenia.
    Carrel T; Berdat P; Schmidli J; Gygax E
    Eur J Cardiothorac Surg; 2001 Apr; 19(4):525-7. PubMed ID: 11306328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of heparin-induced thrombocytopenia and thrombosis.
    Green RM
    Semin Vasc Surg; 1996 Dec; 9(4):292-5. PubMed ID: 8958605
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia.
    Demers C; Ginsberg JS; Brill-Edwards P; Panju A; Warkentin TE; Anderson DR; Turner C; Kelton JG
    Blood; 1991 Nov; 78(9):2194-7. PubMed ID: 1932741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombosis treated with ancrod.
    Brennan MB; MacKean GL
    Can J Surg; 1994 Apr; 37(2):161-4. PubMed ID: 8156472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ancrod: understanding the agent.
    Illig KA; Ouriel K
    Semin Vasc Surg; 1996 Dec; 9(4):303-14. PubMed ID: 8958607
    [No Abstract]   [Full Text] [Related]  

  • 16. Uses of heparin. Ancrod for heparin induced thrombocytopenia.
    Soutar RL; Ginsberg JS
    BMJ; 1993 May; 306(6889):1410. PubMed ID: 8518620
    [No Abstract]   [Full Text] [Related]  

  • 17. Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery.
    Murphy GS; Marymont JH
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):113-26. PubMed ID: 17289495
    [No Abstract]   [Full Text] [Related]  

  • 18. Case 5--1996. Thrombosis after the use of a heparin-coated cardiopulmonary bypass circuit in a patient with heparin-induced thrombocytopenia.
    Van Dyck MJ; Lavenne-Pardonge E; Azerad MA; Matta AG; Moriau M; Comunale ME
    J Cardiothorac Vasc Anesth; 1996 Oct; 10(6):809-15. PubMed ID: 8910165
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin-associated thrombocytopenia and thrombosis: optimal therapy with ancrod.
    Cole CW; Fournier LM; Bormanis J
    Can J Surg; 1990 Jun; 33(3):207-10. PubMed ID: 2190683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of heparin-induced thrombocytopenia.
    Greinacher A
    Thromb Haemost; 1999 Aug; 82(2):457-67. PubMed ID: 10605737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.